Business · 09/06/2008Updated: 10/17/2026 · 1 min read
FDA Approves Supplemental New Animal Drug Application for Moxidectin
Summary
The FDA has approved a supplemental new animal drug application for a sustained-release injectable moxidectin formulation to prevent heartworm disease and treat existing hookworm infections in dogs, as filed by Fort Dodge Animal Health, a division of Wyeth.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →